Ocrelizumab

1 Drug classified under this active ingredient

Monoclonal Antibody. Ocrelizumab 300 mg / 10 ml.
VIAL: 1×10ml. 300 mg IV  infus., follow.  two wks. later by a 2^ND 300 mg IV infus. Subseq. doses: single 600 mg IV infus.  every 6 mnths. See lit.
Tmt. of adult pts. with relaps. or primary progres. forms of multiple sclerosis.
C/I: Hypersens. Active HBV infec. A history of life-threatening infus. reaction to Ocrelizumab.